22 October 2026 Infectious disease oncology Public Health Research Infections linked to one in eight cancers
22 October 2026 Cervical cancer Immunotherapy Pembrolizumab survival benefit persists at five years in cervical cancer
22 October 2026 Cancer Diabetes FDA Pharmaceuticals Multi-cancer blood tests, weekly insulin injections, and new cancer treatments
22 October 2026 Immune Checkpoint Inhibitors Melanoma Research Understanding the drivers of chronic immune-related adverse events
8 October 2026 Breast cancer Mental Health Depression, stress may drive long-term fatigue after breast cancer treatment
8 October 2026 FDA Haematology Pharmaceuticals FDA approves interferon conjugate for essential thrombocythemia
